Arizona Dermatopathology

Arizona Dermatopathology provides specialized dermatopathology services, focusing on precise diagnostics for skin conditions. The company's expertise helps medical professionals deliver accurate patient care through thorough analysis of skin tissue. Arizona Dermatopathology is a diagnostic service provider specializing in dermatopathology, headquartered in Scottsdale, US. The company was acquired by Aurora Diagnostics, LLC in September 2014, though specific financial terms of the acquisition were not disclosed.

The firm has completed at least one notable deal as part of its business operations, aimed at enhancing its service offerings. Arizona Dermatopathology specializes in comprehensive dermatopathology services, focusing on both broad and sub-specialized diagnostic solutions. Their core offerings include the analysis and interpretation of skin tissue samples to diagnose a variety of skin conditions, including cancers and inflammatory diseases. The company’s clientele primarily consists of clinicians, hospitals, and dermatology practices that depend on precise and timely diagnostic information to inform patient care.

Arizona Dermatopathology's services are geared towards enhancing diagnostic accuracy and improving patient outcomes, thereby addressing the critical need for reliable pathology services in the healthcare system. Their diagnostic services are available across various geographical markets, including but not limited to Arizona and potentially neighboring states, catering primarily to healthcare providers seeking expert pathology support. Arizona Dermatopathology generates revenue through a fee-for-service model, where they bill clients for diagnostic tests and pathology services provided. Transactions typically occur directly between the company and healthcare facilities, dermatologists, or other medical professionals who submit tissue specimens for analysis.

The pricing structure reflects the complexity of the services rendered, with costs associated with specific diagnostic tests that are often billed on a per-case basis. Certain specialized tests may command higher fees based on their technical requirements and the expertise involved in their interpretation. Arizona Dermatopathology also engages with insurance providers, facilitating claims processing to streamline payment for diagnostic services rendered, which supports the financial transaction framework within this healthcare niche. Following its acquisition in 2014, Arizona Dermatopathology is positioned to leverage resources for future expansion.

The company is exploring potential new markets, with a focus on increasing its reach in neighboring states. Additionally, future product offerings are expected to be announced, aligning with advancements in dermatopathology. Recent funding from the acquisition will be utilized to support these strategic initiatives, although specific details on the new products and timelines have not been disclosed.